Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Moguisteine, a potential agent for treating allergic cough

March 31, 1998

Peptimmune and Peptide Therapeutics form asthma, autoimmune disease collaboration

March 30, 1998

Inspire, NeoGenesis form respiratory drugs collaboration

March 27, 1998

Byk Gulden claims PDE IV inhibitors for respiratory disorders, dermatoses

March 27, 1998

Novel compounds for allergic/inflammatory disorders discovered at Astra

March 27, 1998

TOBI now available for CF patients with P. aeruginosa

March 26, 1998

HSR-609: a potent and insurmountable H1 antagonist in vitro

March 26, 1998

Hoechst discovers inhibitors of various inflammatory mediators

March 25, 1998

CytoMed and UCB join forces to develop antiinflammatory therapeutics

March 25, 1998

PathoGenesis seeks Canadian approval for TOBI in CF

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...